| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Ophélie Rault, Bruno Romeo, Florence Butlen-Ducuing, Eirini Rari, Amine Benyamina, Catherine Martell. Impact of cannabis use and its cessation on the dosage and the efficacy of antipsychotic drugs in in- and outpatients with schizophrenia taking medication: A systematic review and meta-analysis. Journal of psychiatric research. vol 156. 2022-11-21. PMID:36410310. |
the aim of this meta-analysis and systematic review was to assess the impact of cannabis use on the efficacy of treatments, more particularly regarding the antipsychotic dosage, symptoms evolution, therapeutic resistance and the risk of relapse in patients with schizophrenia taking medication. |
2022-11-21 |
2023-08-14 |
Not clear |
| Ophélie Rault, Bruno Romeo, Florence Butlen-Ducuing, Eirini Rari, Amine Benyamina, Catherine Martell. Impact of cannabis use and its cessation on the dosage and the efficacy of antipsychotic drugs in in- and outpatients with schizophrenia taking medication: A systematic review and meta-analysis. Journal of psychiatric research. vol 156. 2022-11-21. PMID:36410310. |
this meta-analysis provides evidence that previous cannabis use, or occasional use, in patients with schizophrenia taking medication does not impact antipsychotic efficacy as described by antipsychotic dosage or panss score. |
2022-11-21 |
2023-08-14 |
Not clear |
| Karin J H Verweij, Jacqueline M Vink, Abdel Abdellaoui, Nathan A Gillespie, Eske M Derks, Jorien L Treu. The genetic aetiology of cannabis use: from twin models to genome-wide association studies and beyond. Translational psychiatry. vol 12. issue 1. 2022-11-21. PMID:36411281. |
studies that applied multivariate methods (twin models, genetic correlation analysis, polygenic score analysis, genomic structural equation modelling, mendelian randomisation) indicate that there is considerable genetic overlap between cannabis use and other traits (especially other substances and externalising disorders) and some evidence for causal relationships (most convincingly for schizophrenia). |
2022-11-21 |
2023-08-14 |
Not clear |
| Samantha Johnstone, Darby J E Lowe, Karolina Kozak-Bidzinski, Marcos Sanches, David J Castle, Jennifer S Rabin, Rachel A Rabin, Tony P Georg. Neurocognitive moderation of repetitive transcranial magnetic stimulation (rTMS) effects on cannabis use in schizophrenia: a preliminary analysis. Schizophrenia (Heidelberg, Germany). vol 8. issue 1. 2022-11-17. PMID:36384966. |
neurocognitive moderation of repetitive transcranial magnetic stimulation (rtms) effects on cannabis use in schizophrenia: a preliminary analysis. |
2022-11-17 |
2023-08-14 |
human |
| Samantha Johnstone, Darby J E Lowe, Karolina Kozak-Bidzinski, Marcos Sanches, David J Castle, Jennifer S Rabin, Rachel A Rabin, Tony P Georg. Neurocognitive moderation of repetitive transcranial magnetic stimulation (rTMS) effects on cannabis use in schizophrenia: a preliminary analysis. Schizophrenia (Heidelberg, Germany). vol 8. issue 1. 2022-11-17. PMID:36384966. |
repetitive transcranial magnetic stimulation (rtms) is a promising treatment for cannabis use disorder in schizophrenia; however, gaps in the literature remain as to the potential role of neurocognitive functioning in treatment response. |
2022-11-17 |
2023-08-14 |
human |
| Hakan Kayir, Jessica Ruffolo, Patrick McCunn, Jibran Y Khokha. The Relationship Between Cannabis, Cognition, and Schizophrenia: It's Complicated. Current topics in behavioral neurosciences. 2022-11-01. PMID:36318403. |
the relationship between cannabis, cognition, and schizophrenia: it's complicated. |
2022-11-01 |
2023-08-14 |
human |
| Hakan Kayir, Jessica Ruffolo, Patrick McCunn, Jibran Y Khokha. The Relationship Between Cannabis, Cognition, and Schizophrenia: It's Complicated. Current topics in behavioral neurosciences. 2022-11-01. PMID:36318403. |
cannabis use has multifaceted impacts on cognition in schizophrenia patients and healthy subjects. |
2022-11-01 |
2023-08-14 |
human |
| Hakan Kayir, Jessica Ruffolo, Patrick McCunn, Jibran Y Khokha. The Relationship Between Cannabis, Cognition, and Schizophrenia: It's Complicated. Current topics in behavioral neurosciences. 2022-11-01. PMID:36318403. |
cannabis use in schizophrenia has been associated with symptom exacerbation, longer and more frequent psychotic episodes, and poorer treatment outcomes. |
2022-11-01 |
2023-08-14 |
human |
| Hakan Kayir, Jessica Ruffolo, Patrick McCunn, Jibran Y Khokha. The Relationship Between Cannabis, Cognition, and Schizophrenia: It's Complicated. Current topics in behavioral neurosciences. 2022-11-01. PMID:36318403. |
multiple factors need to be considered to understand the complex relationship between cannabis, cognitive function, and schizophrenia. |
2022-11-01 |
2023-08-14 |
human |
| Hakan Kayir, Jessica Ruffolo, Patrick McCunn, Jibran Y Khokha. The Relationship Between Cannabis, Cognition, and Schizophrenia: It's Complicated. Current topics in behavioral neurosciences. 2022-11-01. PMID:36318403. |
cannabidiol (cbd), on the other hand, can improve cognitive deficits seen in neurodevelopmental and chemically-induced animal models of schizophrenia. |
2022-11-01 |
2023-08-14 |
human |
| Inés Ibarra-Lecue, Paula Unzueta-Larrinaga, Rocío Barrena-Barbadillo, Aitor Villate, Igor Horrillo, Begoña Mendivil, Miguel A Landabaso, J Javier Meana, Nestor Etxebarria, Luis F Callado, Leyre Urigüe. Cannabis use selectively modulates circulating biomarkers in the blood of schizophrenia patients. Addiction biology. vol 27. issue 6. 2022-10-27. PMID:36301212. |
cannabis use selectively modulates circulating biomarkers in the blood of schizophrenia patients. |
2022-10-27 |
2023-08-14 |
human |
| Inés Ibarra-Lecue, Paula Unzueta-Larrinaga, Rocío Barrena-Barbadillo, Aitor Villate, Igor Horrillo, Begoña Mendivil, Miguel A Landabaso, J Javier Meana, Nestor Etxebarria, Luis F Callado, Leyre Urigüe. Cannabis use selectively modulates circulating biomarkers in the blood of schizophrenia patients. Addiction biology. vol 27. issue 6. 2022-10-27. PMID:36301212. |
cannabis use disorder is frequent in schizophrenia patients, and it is associated with an earlier age of onset and poor schizophrenia prognosis. |
2022-10-27 |
2023-08-14 |
human |
| Inés Ibarra-Lecue, Paula Unzueta-Larrinaga, Rocío Barrena-Barbadillo, Aitor Villate, Igor Horrillo, Begoña Mendivil, Miguel A Landabaso, J Javier Meana, Nestor Etxebarria, Luis F Callado, Leyre Urigüe. Cannabis use selectively modulates circulating biomarkers in the blood of schizophrenia patients. Addiction biology. vol 27. issue 6. 2022-10-27. PMID:36301212. |
results showed that both platelet 5-ht2ar and the active phospho (ser473)akt protein expression were significantly increased in schizophrenia subjects, whereas patients with a dual diagnosis of schizophrenia and cannabis use disorder did not show significant changes. |
2022-10-27 |
2023-08-14 |
human |
| Inés Ibarra-Lecue, Paula Unzueta-Larrinaga, Rocío Barrena-Barbadillo, Aitor Villate, Igor Horrillo, Begoña Mendivil, Miguel A Landabaso, J Javier Meana, Nestor Etxebarria, Luis F Callado, Leyre Urigüe. Cannabis use selectively modulates circulating biomarkers in the blood of schizophrenia patients. Addiction biology. vol 27. issue 6. 2022-10-27. PMID:36301212. |
results demonstrate that schizophrenia subjects show different circulating markers pattern depending on the associated diagnosis of cannabis use disorder, supporting the hypothesis that there could be different underlying mechanisms that may explain clinical differences among these groups. |
2022-10-27 |
2023-08-14 |
human |
| Elisabetta C Del R. Emerging themes in schizophrenia research at SIRS 2022: Inclusivity, equality and Cannabis impact on mental health. Schizophrenia research. vol 250. 2022-10-17. PMID:36252295. |
emerging themes in schizophrenia research at sirs 2022: inclusivity, equality and cannabis impact on mental health. |
2022-10-17 |
2023-08-14 |
Not clear |
| Mathilde Argote, Guillaume Sescousse, Jérôme Brunelin, Eric Fakra, Mikail Nourredine, Benjamin Rollan. Association between formal thought disorder and cannabis use: a systematic review and meta-analysis. Schizophrenia (Heidelberg, Germany). vol 8. issue 1. 2022-09-29. PMID:36175509. |
subgroup analyses revealed that ftd severity was increased among cannabis users, regardless of the disorder severity: healthy individuals (smd = 0.19, 95%ci [0.05-0.33], p = 0.02); patients with first-episode psychosis (smd = 0.21, 95%ci [0.01-0.41], p = 0.04); patients with schizophrenia (smd = 0.25, 95%ci [0.11-0.38], p = 0.005). |
2022-09-29 |
2023-08-14 |
Not clear |
| Abhishek Ghosh, Simranjit Kaur, Raghav Shah, Fareed Oomer, Ajit Avasthi, Chirag K Ahuja, Debasish Basu, Ritu Nehra, Niranjan Khandelwa. Surface-based brain morphometry in schizophrenia vs. cannabis-induced psychosis: A controlled comparison. Journal of psychiatric research. vol 155. 2022-09-28. PMID:36170756. |
we examined group differences in cortical thickness and surface-parameters among age and handedness--matched persons with cannabis-induced psychosis (cip), schizophrenia with heavy cannabis use (szc), and healthy controls (hc). |
2022-09-28 |
2023-08-14 |
Not clear |
| Laura Fusar-Poli, Lotta-Katrin Pries, Jim van Os, Rajiv Radhakrishnan, Ayşegül Yay Pençe, Gamze Erzin, Philippe Delespaul, Gunter Kenis, Jurjen J Luykx, Bochao D Lin, Berna Akdede, Tolga Binbay, Vesile Altınyazar, Berna Yalınçetin, Güvem Gümüş-Akay, Burçin Cihan, Haldun Soygür, Halis Ulaş, Eylem Şahin Cankurtaran, Semra Ulusoy Kaymak, Marina M Mihaljevic, Sanja Andric-Petrovic, Tijana Mirjanic, Miguel Bernardo, Gisela Mezquida, Silvia Amoretti, Julio Bobes, Pilar A Saiz, Maria Paz García-Portilla, Julio Sanjuan, Eduardo J Aguilar, José Luis Santos, Estela Jiménez-López, Manuel Arrojo, Angel Carracedo, Gonzalo López, Javier González-Peñas, Mara Parellada, Nadja P Maric, Cem Atbaşoğlu, Alp Üçok, Köksal Alptekin, Meram Can Saka, Eugenio Aguglia, Celso Arango, Bart Pf Rutten, Sinan Guloksu. The association between cannabis use and facial emotion recognition in schizophrenia, siblings, and healthy controls: Results from the EUGEI study. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 63. 2022-09-02. PMID:36055075. |
cannabis represents one established environmental factor associated with the onset and progression of schizophrenia. |
2022-09-02 |
2023-08-14 |
Not clear |
| Laura Fusar-Poli, Lotta-Katrin Pries, Jim van Os, Rajiv Radhakrishnan, Ayşegül Yay Pençe, Gamze Erzin, Philippe Delespaul, Gunter Kenis, Jurjen J Luykx, Bochao D Lin, Berna Akdede, Tolga Binbay, Vesile Altınyazar, Berna Yalınçetin, Güvem Gümüş-Akay, Burçin Cihan, Haldun Soygür, Halis Ulaş, Eylem Şahin Cankurtaran, Semra Ulusoy Kaymak, Marina M Mihaljevic, Sanja Andric-Petrovic, Tijana Mirjanic, Miguel Bernardo, Gisela Mezquida, Silvia Amoretti, Julio Bobes, Pilar A Saiz, Maria Paz García-Portilla, Julio Sanjuan, Eduardo J Aguilar, José Luis Santos, Estela Jiménez-López, Manuel Arrojo, Angel Carracedo, Gonzalo López, Javier González-Peñas, Mara Parellada, Nadja P Maric, Cem Atbaşoğlu, Alp Üçok, Köksal Alptekin, Meram Can Saka, Eugenio Aguglia, Celso Arango, Bart Pf Rutten, Sinan Guloksu. The association between cannabis use and facial emotion recognition in schizophrenia, siblings, and healthy controls: Results from the EUGEI study. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 63. 2022-09-02. PMID:36055075. |
better fer performance as indicated by higher dfar-total scores was associated with lifetime regular cannabis use in schizophrenia (b = 1.36, 95% ci 0.02 to 2.69), siblings (b = 2.17, 95% ci 0.79 to 3.56), and hc (b = 3.10, 95% ci 1.14 to 5.06). |
2022-09-02 |
2023-08-14 |
Not clear |
| Laura Fusar-Poli, Lotta-Katrin Pries, Jim van Os, Rajiv Radhakrishnan, Ayşegül Yay Pençe, Gamze Erzin, Philippe Delespaul, Gunter Kenis, Jurjen J Luykx, Bochao D Lin, Berna Akdede, Tolga Binbay, Vesile Altınyazar, Berna Yalınçetin, Güvem Gümüş-Akay, Burçin Cihan, Haldun Soygür, Halis Ulaş, Eylem Şahin Cankurtaran, Semra Ulusoy Kaymak, Marina M Mihaljevic, Sanja Andric-Petrovic, Tijana Mirjanic, Miguel Bernardo, Gisela Mezquida, Silvia Amoretti, Julio Bobes, Pilar A Saiz, Maria Paz García-Portilla, Julio Sanjuan, Eduardo J Aguilar, José Luis Santos, Estela Jiménez-López, Manuel Arrojo, Angel Carracedo, Gonzalo López, Javier González-Peñas, Mara Parellada, Nadja P Maric, Cem Atbaşoğlu, Alp Üçok, Köksal Alptekin, Meram Can Saka, Eugenio Aguglia, Celso Arango, Bart Pf Rutten, Sinan Guloksu. The association between cannabis use and facial emotion recognition in schizophrenia, siblings, and healthy controls: Results from the EUGEI study. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 63. 2022-09-02. PMID:36055075. |
patients with schizophrenia who started to use cannabis after the age of 16 showed better fer performance than patients who started earlier (b = 2.50, 95% ci 0.15 to 4.84) and non-users (b = 3.72, 95 ci 1.96 to 5.49). |
2022-09-02 |
2023-08-14 |
Not clear |